Tags:
yes it is a Canadian trial but from what I'm being told it is being monitored by the FDA for future approval consideration. So if Accererlon wants the FDA to accept the results they need to allow their input.
At least that's my understanding of what I was told :)
And this being a dosing trial, I'm assuming all the data obtained in the Canadian trial is part of the package sent to the FDA for approval of start of US trials.
There was a lot of noise about this trial last year before and after Shire came on-board... we did not hear anything for a while now.
Hi,
Suppose that ACE 031 is effective in muscles but causes nose bleeds,so in that case will this drug be approved based on a fact that Steroids cause many serious side effcts but they are approved in DMD?!
Can anybody elaborate on this?
Hearing about the nose bleed i am disappointement and losing hope. I hope i am wrong and they can figure something out please please....
You know,I am full of hope,and I feel that this disease will be under control soon.
I heard that nose bleeds is just in those who receive high dose
As for the nosebleeds... they were in the second cohort.
The dosings were 0.5, 1.0, ....and 2.0 which was to be lowered to 1.5 and hasn't started due to the hold.
2.0 was what the healthy adults were given.
You know,I am full of hope,and I feel that this disease will be under control soon.
I heard that nose bleeds is just in those who receive high dose
We are not privy to any of the results except our own, so I have no idea how other boys responded. I just know that we didn't really see any functional improvement. His strength and function testing seemed to remain consistent.
He was only on it for the initial three months so who knows if we will better results longer term.
© 2023 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service